Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
Vaccine
; 27(32): 4350-4, 2009 Jul 09.
Article
en En
| MEDLINE
| ID: mdl-19487057
ABSTRACT
OBJECTIVE:
To investigate the rabies virus neutralizing antibody response in HIV-1-infected patients with CD4+ cell countMETHODS:
In a prospective cohort study, 27 HIV-1 infected patients were recruited, none of which had a history of rabies vaccination. All patients provided informed consent and were separated into two groups according to their CD4+ cell count (patients with CD4+ counts ofRESULTS:
Of the 27 patients included in the study, 18 patients (67%) had CD4+ cell counts of >200 cells/microL and 9 patients (33%) had CD4+ counts ofCONCLUSION:
PCECV is immunogenic in HIV-1-infected patients with CD4+ cell counts below 200 cells/microL when administered in a modified eight-site intradermal PEP regimen.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Rabia
/
Vacunas Antirrábicas
/
Infecciones por VIH
/
Vacunación
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Vaccine
Año:
2009
Tipo del documento:
Article
País de afiliación:
Tailandia